Agenda – 4th Rx-to-OTC Switch Summit

  • Day One
  • Day Two

Day One

 Conference Day 1 - December 6, 2017

9:15AM – 12:15PM

WORKSHOP:
HOW TO GUIDE YOUR ORGANIZATION THROUGH AN RX-TO-OTC SWITCH

Susan B. Levy, Founder and Principal, SUSAN B. LEVY CONSULTING

12:15PM – 1:15PM

LUNCHEON

1:15PM – 2:00PM

ACCESS AND EMPLOYER/CONSUMER TRENDS THAT IMPACT RX-TO-OTC PRODUCTS
Randy Vogenberg, Ph.D., R.Ph., Principal, Institute for Integrated Healthcare, Fellow, Foundation of HealthSmart Consumers, Lead Collaborator, National Institute of Collaborative Healthcare

2:45PM – 3:15PM

NETWORKING BREAK

3:15PM – 4:00PM

SUCCESSFUL SWITCHED CASE STUDY: BEST PRACTICES AND INSIGHT FROM GALDERMA ON SUCCESSFUL RX-TO-OTC SWITCHES
James Kenney, Global Brand Marketing Director, GALDERMA
Sean Griffin, Senior Director of Regulatory Affairs, GALDERMA

4:00PM – 4:45PM

NOVEL STRATEGIES TO MAXIMIZE SWITCH COMMERCIAL SUCCESS
Susan Lavine Coleman, President, NCI CONSULTING


Day Two

 Conference Day 2 - December 7, 2017

8:15AM – 9:00AM

CONTINENTAL BREAKFAST

9:15AM – 10:00AM

PANEL: MEDICAL — COMMERCIAL PARTNERSHIP: A KEY TO SUCCESSFUL SWITCH
Philip Kantor, Principal, QuintilesIMS Consumer Health Consulting; former Global Marketing Director, Allergy, GLAXOSMITHKLINE
Juby Jacob-Nara, former CMO and Vice President, Global Clinical Development and Global Medical Affairs, PFIZER

10:00AM – 11:00AM

PANEL: DRIVE INNOVATIVE MEDICAL AND REGULATORY STRATEGIES AND INTERACT EFFECTIVELY WITH THE FDA
Sean Griffin, Senior Director of Regulatory Affairs, GALDERMA

11:00AM – 11:30AM

NETWORKING BREAK

11:30AM – 12:15PM

POTENTIAL FUTURE OTC SWITCHES FROM A PHARMACIST’S PERSPECTIVE
Randall Thornton, Clinical Pharmacist, EMORY HEALTHCARE

12:15PM – 1:15PM

LUNCHEON

1:15PM – 2:00PM

EXPLORE POLICY AND PROGRAM IMPLICATIONS OF A NALOXONE RX-OTC SWITCH
Erin E. Haas, MPH, Prevention Policy Manager, Maryland Department of Health Behavioral Health Administration
Corey Davis, Deputy Director and Staff Attorney, Network for Public Health Law

2:00PM – 2:45PM

UNDERSTANDING KEY ELEMENTS OF CONSUMER BEHAVIOR STUDIES IN A COMPLEX RX-TO-OTC SWITCH
Edwin Hhemwall, Ph.D., Principal, EDWIN HEMWALL LLC REGULATORY AND SCIENTIFIC CONSULTING SERVICE